SHENZHEN, China — MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in the life sciences, today announced the acquisition of STOmics and CycloneSEQ. It marks a significant milestone in MGI’s “SEQALL+GLI+Omics” strategy, positioning the company as the world’s only manufacturer of core life science tools spanning short-read […]
Divestiture streamlines operations and advances the Company’s strategy to fully exit non-core activities LOS ANGELES — Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces the sale of its ChromaDex Reference Standards business to LGC, as of February 24, 2026, in […]
The acquisition further enhances LGC’s ability to support pharmaceutical, food, and testing laboratories with trusted reference materials that underpin safety, quality, and regulatory confidence. London, UK — LGC Group, a global leader in life sciences, diagnostics, and analytical solutions, today announced the acquisition of the ChromaDex Reference Standards portfolio from Niagen Bioscience (NASDAQ: NAGE). The acquisition expands […]
SAN JOSE, Calif. and BASEL, Switzerland — Complete Genomics, a U.S.-based innovator in genomic sequencing technology, today confirmed that it has entered into a definitive agreement, subject to customary closing conditions and approval by MGI shareholders, under which it will be acquired by Swiss Rockets AG, a Switzerland-based life sciences group. The transaction will enable the scaling of the […]
Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models Strengthens position as the leading independent provider of physiologically-relevant in vitro retinal models for ophthalmology drug discovery and safety testing Cambridge, UK and Newcastle, UK — Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug […]
Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications Announces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials Sciences MILFORD, Mass. — Waters Corporation (NYSE: WAT) (“Waters”) today announced it has completed […]
Paris and Palo Alto – LBO France, a multi-specialist investment platform and pioneer in private equity, announced today the signing of a definitive agreement with Vivo Capital, a leading global investment firm focused exclusively on healthcare and life sciences, for the sale of Dutscher Group (‘Dutscher’ or ‘the Group’), the European leader in consumables and equipment distribution […]
Establishing an R&D Footprint in India for Analytical and Measurement Solutions for Advanced Materials HORIBA India Private Limited (Head Office: New Delhi, India; President: Rajeev Gautam), a HORIBA Group company, announces that it has completed the acquisition of 100% of the shares of Pristine Deeptech Private Limited*1 (Head Office: Gujarat, India; CEO: Ashvani Kumar; hereinafter “Pristine […]
SSI Diagnostica Group strengthens life science portfolio for vaccine development and quality control with acquisition of US-based multiplexing company Copenhagen — SSI Diagnostica Group, a global company specializing in testing solutions for infectious diseases, has announced the acquisition of InDevR, a Colorado-based provider of advanced multiplexed solutions for vaccine testing and quality control. The addition strengthens […]
MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select intellectual property and other assets related to PacBio’s short-read DNA sequencing technology and related clustering, sequencing reagent, and detection technologies to Illumina, Inc. PacBio received $48.1 million in net cash […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
